Abstract:BACKGROUND:Randomized controlled trials are considered the gold standard for evaluating experimental treatments but often require large sample sizes. Single-arm trials require smaller sample sizes but are subject to bias when using historical control data for comparative inferences. This article presents a Bayesian adaptive synthetic-control design that exploits historical control data to create a hybrid of a single-arm trial and a randomized controlled trial.METHODS:The Bayesian adaptive synthetic control design has two stages. In stage 1, a prespecified number of patients are enrolled in a single arm given the experimental treatment. Based on the stage 1 data, applying propensity score matching and Bayesian posterior prediction methods, the usefulness of the historical control data for identifying a pseudo sample of matched synthetic-control patients for making comparative inferences is evaluated. If a sufficient number of synthetic controls can be identified, the single-arm trial is continued. If not, the trial is switched to a randomized controlled trial. The performance of The Bayesian adaptive synthetic control design is evaluated by computer simulation.RESULTS:The Bayesian adaptive synthetic control design achieves power and unbiasedness similar to a randomized controlled trial but on average requires a much smaller sample size, provided that the historical control data patients are sufficiently comparable to the trial patients so that a good number of matched controls can be identified in the historical control data. Compared to a single-arm trial, The Bayesian adaptive synthetic control design yields much higher power and much smaller bias.CONCLUSION:The Bayesian adaptive synthetic-control design provides a useful tool for exploiting historical control data to improve the efficiency of single-arm phase II clinical trials, while addressing the problem of bias when comparing trial results to historical control data. The proposed design achieves power similar to a randomized controlled trial but may require a substantially smaller sample size.

The method of minimization for random allocation in clinical trials: introduction and its SAS program

The Balance Comparison among Simple Randomization, Stratified Blocked Randomization and Minimization

Sequential Covariate-Adjusted Randomization Via Hierarchically Minimizing Mahalanobis Distance and Marginal Imbalance.

Mathematical programming tools for randomization purposes in small two‐arm clinical trials: A case study with real data

Mathematical programming tools for randomization purposes in small two-arm clinical trials: A case study with real data

The Application of Central Randomization System in Clinical Trials

A Bayesian Response-Adaptive Covariate-Balanced Randomization Design with Application to A Leukemia Clinical Trial

The Formal Definition and Optimization of Minimization Random Algorithm

Application of Bayesian Dynamic Linear Models to Random Allocation Clinical Trials

Approximation to the optimal allocation for response adaptive designs

Using random allocation book for random allocation concealment in a clinical trial

Model-based optimal randomization procedure for treatment–covariate interaction tests

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

Asymptotic properties of covariate-adaptive randomization

Adaptive Allocation Theory in Clinical Trials

Adaptive Clinical Trials: Exploiting Sequential Patient Recruitment and Allocation

Exploring Statistical Methods in Clinical Trials When Some of the Patients are Treated against the Randomization

Inference on Average Treatment Effect under Minimization and Other Covariate-Adaptive Randomization Methods

Consistent Covariance estimation for stratum imbalances under minimization method for covariate-adaptive randomization

[An Effective Method to Reduce Bias Between Two Compared Groups: Propensity Score].

Subgroup identification in clinical trials: an overview of available methods and their implementations with R